Immunoreactivity of neuron-specific enolase (NSE) in human pancreas in health and type 1 diabetes mellitus

Bull Exp Biol Med. 2010 Nov;149(6):763-7. doi: 10.1007/s10517-010-1047-4.

Abstract

The role of neuron-specific enolase (glycolytic enzyme; marker of nerve fibers and Langerhans islet in human pancreas) in the development of type 1 diabetes mellitus was studied in autopsy specimens from 6 adult patients. Autopsied specimens of the pancreas from 7 subjects without carbohydrate metabolism disorders served as the control. Autopsied specimens of the pancreas from a child with the clinical diagnosis of type 1 diabetes mellitus, a child without carbohydrate metabolism disorders, and from 7 human fetuses of 15-40 weeks gestation were also studied. In control specimens, the neuron-specific enolase was detected in the pancreatic nerve fibers and Langerhans islets. Studies of pancreatic tissue specimens from adult patients with type 1 diabetes mellitus showed no immunopositive reaction to neuron-specific enolase in insulin-negative specimens. A possible mechanism of type 1 diabetes mellitus development is suggested.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Case-Control Studies
  • Diabetes Mellitus, Type 1 / enzymology*
  • Humans
  • Immunohistochemistry
  • Insulin / metabolism
  • Insulin Secretion
  • Islets of Langerhans / enzymology*
  • Islets of Langerhans / metabolism
  • Phosphopyruvate Hydratase / metabolism*

Substances

  • Insulin
  • Phosphopyruvate Hydratase